Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis
1 other identifier
observational
40
1 country
1
Brief Summary
In this research, we will use established surveys to look at the relationship between various styles of coping with a disease, religious coping styles, treatment compliance, locus of control, broad measures of mental health and adjustment, and basic health data (e.g., PFTs, recent hospitalizations or antibiotics within the past year, lung microbiology, CFTR mutations, and co-morbid conditions such as diabetes, depression, and liver disease). While the research is correlational, it should suggest relationships (both positive and negative) between various coping styles and desired outcomes (compliance and well-being).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2007
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 18, 2007
CompletedFirst Posted
Study publicly available on registry
December 20, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2008
CompletedNovember 24, 2009
November 1, 2009
December 18, 2007
November 23, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Multiple measures of coping strategies in adolescents with cystic fibrosis.
Single visit
Secondary Outcomes (1)
Coping startegies will be correlated with measures of clinical illness.
Single visit
Study Arms (1)
1
Adolescents with CF.
Eligibility Criteria
Adolescents age 13-19 with CF at a single CF center.
You may qualify if:
- cystic fibrosis age 13-19 yrs
You may not qualify if:
- acutely ill
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Akron Children's Hospital
Akron, Ohio, 44308, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nathan C Kraynack, MD
Akron Children's Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 18, 2007
First Posted
December 20, 2007
Study Start
October 1, 2007
Study Completion
April 1, 2008
Last Updated
November 24, 2009
Record last verified: 2009-11